Stephen Ansell, MD, PhD¹, Philippe Armand, MD, PhD², John M. Timmerman, MD³, Margaret A. Shipp, MD², M Brigid Bradley Garelik, MD^4*, Lili Zhu, MS^5* and Alexander M. Lesokhin, MD⁶

¹Mayo Clinic, Rochester, MN
²Dana-Farber Cancer Institute, Boston, MA
³UCLA Medical Center, Los Angeles, CA
⁴Bristol-Myers Squibb, Wallingford, CT
⁵Bristol-Myers Squibb, Princeton, NJ
⁶Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Philippe Armand, MD, PhD¹, Margaret A. Shipp, MD¹, Vincent Ribrag, MD², Jean-Marie Michot^3*, Pier Luigi Zinzani, MD, PhD⁴, Martin Gutierrez, MD^5*, Ellen Snyder, PhD^6*, Alejandro D. Ricart, MD^6*, Arun Balakumaran, MD, PhD, SM^6* and Craig H. Moskowitz, MD⁷

¹Dana-Farber Cancer Institute, Boston, MA
²DITEP/medicine, Gustave Roussy Cancer Campus, Villejuif, France
³Gustave Roussy Comprehensive Cancer Center, Villejuif, France
⁴Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
⁵John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁶Merck & Co., Inc., Kenilworth, NJ
⁷Memorial Sloan Kettering Cancer Center, New York, NY

Catherine S. Diefenbach, MD¹, Fangxin Hong, Ph.D.², Jonathon B. Cohen, MD³, Michael J. Robertson, MD⁴, Richard F. Ambinder, MD, PhD⁵, Timothy S. Fenske, MD⁶, Ranjana H Advani, MD⁷, Brad S Kahl, MD⁸ and Stephen Ansell, MD, PhD⁹

¹NYU Perlmutter Cancer Center, NYU School of Medicine, New York, NY
²Dana-Farber Cancer Institute, Boston, MA
³Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁴Lymphoma Program, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
⁵Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins Medical Institutions, Baltimore, MD
⁶Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
⁷Stanford University Medical Center, Stanford, CA
⁸Washington University, St.Louis, MO
⁹Mayo Clinic, Rochester, MN

Ahmed Sawas, MD¹, Joseph M. Connors, MD², John G. Kuruvilla, MD³, Celeste Rojas^4*, Renee Lichtenstein^5*, Ellen Neylon, NP^6*, Emily Lichtenstein, RN^1*, Changchun Deng, MD, PhD¹, Jennifer E Amengual, MD¹, Diego Villa, MD, MPH⁷, Michael Crump, MD⁸ and Owen A. O'Connor, MD, PhD^9*

¹Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY
²British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
³Division of Medical Oncology and Hematology, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
⁵Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York
⁶Center for Lymphoid Malignancies at Columbia University Medical Center, New York, NY
⁷BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada
⁸Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
⁹Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY

Christopher A. Yasenchak, MD¹, Andres Forero-Torres², Vivian Jean Mikao Cline-Burkhardt^3*, Rodolfo E Bordoni, MD^4*, Dipti Patel-Donnelly, MD⁵, Patrick J. Flynn, MD⁶, Robert Chen⁷, Abraham Fong⁸ and Jonathan W. Friedberg, MD, MMSc⁹

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR
²University of Alabama at Birmingham, Birmingham, AL
³Texas Oncology-Round Rock Seton Williamson, Round Rock, TX
⁴Georgia Cancer Specialists, Marietta, GA
⁵Virginia Cancer Specialists/US Oncology Research, Fairfax, VA
⁶Minnesota Oncology, Woodbury, MN
⁷City of Hope National Medical Center, Duarte, CA
⁸Seattle Genetics, Inc., Bothell, WA
⁹University of Rochester, Rochester, NY

Yassine Al Tabaa, MD, PhD^1*, Michel Meignan, MD, PhD^2*, Scherman Elodie, MD^3*, Corinne Haioun, MD, PhD⁴, Pauline Brice, MD⁵, Catherine Thieblemont⁶, Pascal Merlet, MD^7*, Denis Mariano Goulart, MD, PhD^1* and Guillaume Cartron, MD, PhD^8*

¹Nuclear Medicine, CHRU Montpellier, Montpellier, France
²Nuclear Medicine, AP-HP Groupe Hospitalier Mondor, Créteil, France
³Lymphoid Malignancies Unit, AP-HP Groupe Hospitalier Mondor, Créteil, France
⁴Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France
⁵Hematology, AP-HP Hopital Saint-Louis, Paris, France
⁶Hôpital Saint-Louis, Paris, France
⁷Nuclear Medicine, AP-HP Hôpital Saint Louis, Paris, France
⁸Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France